Four firms to try out rail safety devices

In the preliminary phase of testing, each company will install its systems at three road-rail crossings and in two locomotives.

By SYBIL ERLICH
October 11, 2006 08:12

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Israel Railways has chosen four companies to carry out a pilot installation of identification and detection systems at road-rail level crossings. The companies are Orad Control Systems Ltd., Elta Systems Ltd., Ortech Ltd. and Magal Security Systems Ltd. In the next few months, the companies will carry out controlled trials to determine rates of detection, the number of false alarms, maximum detection and warning time, the number of system failures and the method of system control. In the preliminary phase of testing, each company will install its systems at three road-rail crossings and in two locomotives. The trial is expected to take six months after which the winner will install its detection and warning systems at every level crossing for a further trial period of three months.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS